Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha I Biomedicals IncfiledCriticalAlpha I Biomedicals Inc
Priority to CO94003132ApriorityCriticalpatent/CO4180609A1/en
Publication of CO4180609A1publicationCriticalpatent/CO4180609A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
1. COMPUESTO DE LA FORMULA: R1 - X - R2 - Y (I) EN DONDE X ES Ser-Asp-Ala-Val-Thr-Ser-Ser-Glu-Ile- Thr-Thr-Lys-Asp-Leu-Leys-Glu-Lys-Glu-Glu-Ala-Glu O UN DERIVADO O UN FRAGMENTO DEL MISMO BIOLOGICAMEN- TE ACTIVO, RZ, ES Ac o Z EN DONDE, Ac ES UN GRUPO ACETILENO Y Z ES FIGURA 1 EN DONDE Ac y X SE DEFINEN ANTERIORMENTE; R2 ES Asp; p Asp; R3 ES Asn o Asp o Asp; y Y ES -OH - -NH2; CON LA CONDICION DE QUE CUANDO R1 SEA AC Y R2 SEA Asn, Y SEA -NH2.1. COMPOUND OF THE FORMULA: R1 - X - R2 - Y (I) WHERE X IS Ser-Asp-Ala-Val-Thr-Ser-Ser-Glu-Ile- Thr-Thr-Lys-Asp-Leu-Leys -Glu-Lys-Glu-Glu-Ala-Glu OR A DERIVATIVE OR FRAGMENT OF THE SAME ACTIVE BIOLOGICALLY, RZ, IS Ac or Z WHERE, Ac IS AN ACETYLENE GROUP AND Z IS FIGURE 1 WHERE Ac and X ARE DEFINED PREVIOUSLY; R2 ES Asp; p Asp; R3 IS Asn or Asp or Asp; and Y IS -OH - -NH2; WITH THE CONDITION THAT WHEN R1 IS AC AND R2 IS Asn, AND IS -NH2.
CO94003132A1994-02-011994-02-01
DERIVATIVES OF THYMOSINE ALPHA-1
CO4180609A1
(en)